Page last updated: 2024-11-06

salvin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

salvin: a biocyclic diterpenoid; from sage and rosemary (Lamiaceae) [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID65126
CHEMBL ID484853
CHEBI ID65585
SCHEMBL ID9923661
MeSH IDM0069806

Synonyms (63)

Synonym
AC-6030
NSC694080 ,
NCI60_033653
SMP2_000204
carnosic acid ,
3650-09-7
UPCMLD-DP056:001
UPCMLD-DP056
nsc-694080
NCGC00161623-01
salvin
4a(2h)-phenanthrenecarboxylic acid, 1,3,4,9,10,10a-hexahydro-5,6-dihydroxy-1,1-dimethyl-7-(1-methylethyl)-, (4ar-trans)-
(4ar,10as)-5,6-dihydroxy-1,1-dimethyl-7-propan-2-yl-2,3,4,9,10,10a-hexahydrophenanthrene-4a-carboxylic acid
CHEMBL484853
carsonic acid
chebi:65585 ,
li791sxt24 ,
unii-li791sxt24
podocarpa-8,11,13-trien-17-oic acid, 11,12-dihydroxy-13-isopropyl-
C2488
BCP9000491
S3838
bdbm50371232
BCPP000299
BCP0726000155
AKOS015901362
11,12-dihydroxy-13-isopropylpodocarpa-8,11,13-trien-17-oic acid
(4ar,10as)-5,6-dihydroxy-1,1-dimethyl-7-(propan-2-yl)-1,3,4,9,10,10a-hexahydrophenanthrene-4a(2h)-carboxylic acid
11,12-dihydroxyabieta-8,11,13-trien-20-oic acid
CCG-207954
carnosic acid [usp-rs]
carnosic acid (constituent of rosemary) [dsc]
(4ar,10as)-1,3,4,9,10,10a-hexahydro-5,6-dihydroxy-1,1-dimethyl-7-(1-methylethyl)-4a(2h)-phenanthrenecarboxylic acid
carnosic acid [inci]
carnosic acid [mi]
SCHEMBL9923661
carnosic-acid
mfcd02259459
carnosic acid from rosmarinus officinalis, >=91%, powder
carnosic acid, analytical standard
carnosic acid, primary pharmaceutical reference standard
carnosic acid, united states pharmacopeia (usp) reference standard
139236-75-2
SR-05000002202-2
sr-05000002202
(4ar,10as)-5,6-dihydroxy-1,1-dimethyl-7-propan-2-yl-2,3,4,9,10,10a-hexahydrophenanthrene-4a-carboxylicacid
C21818
QRYRORQUOLYVBU-VBKZILBWSA-N
carnosicacid
rosamox
DTXSID20904450
Q412827
HY-N0644
CS-0009671
deoxypicrosalvinic acid
carnosic acid
(4ar,10as)-5,6-dihydroxy-7-isopropyl-1,1-dimethyl-1,2,3,4,4a,9,10,10a-octahydrophenanthrene-4a-carboxylic acid
C3477
AS-31052
A918580
4a(2h)-phenanthrenecarboxylic acid, 1,3,4,9,10,10a-hexahydro-5,6-dihydroxy-1,1-dimethyl-7-(1-methylethyl)-, (4ar,10as)-rel-
carnosic acid (constituent of rosemary)
carnosic acid (usp-rs)

Research Excerpts

Overview

Salvin is a preparation of Salvia officinalis L.

ExcerptReferenceRelevance
"Salvin is a preparation of Salvia officinalis L. "( [Effect of salvin on the incorporation of labeled precursors into macromolecular compounds of Staphylococcus aureus 209P].
Mashkovskiĭ, NN; Pavlenko, LV; Smirnov, VV, 1989
)
2.11

Toxicity

ExcerptReferenceRelevance
" When embryos were simultaneously exposed to ACR and the natural antioxidative substance carnosic acid (CA), the presence of the latter (10 μM) markedly counteracted the above ACR-induced toxic effects."( Carnosic acid attenuates acrylamide-induced retinal toxicity in zebrafish embryos.
Akhtar, S; Albalawi, A; Alhasani, RHA; Biswas, L; Reilly, J; Shu, X, 2018
)
0.48

Compound-Compound Interactions

ExcerptReferenceRelevance
" This study was conducted to determine the effect of tomato lycopene alone, or in combination with other natural antioxidants, on LDL oxidation."( Lycopene synergistically inhibits LDL oxidation in combination with vitamin E, glabridin, rosmarinic acid, carnosic acid, or garlic.
Aviram, M; Fuhrman, B; Rosenblat, M; Volkova, N, 2000
)
0.31
" This study examined the effects of 1,25(OH)2D3 in combination with carnosic acid on monocytic differentiation as well as intracellular reactive oxygen species (ROS) and Ca2+ levels in human leukemia HL-60 cells."( [Enhancement of differentiation induction of HL-60 cells by 1,25-dihydroxyvitamin D3 in combination with carnosic acid].
An, HP; Chen, JJ; Ren, LH, 2008
)
0.35
"Low concentration of 1,25(OH)2D3 combined with 10 micromol/L carnosic acid can produce enhanced differentiation, proliferation inhibition and antioxidant effects of HL-60 cells."( [Enhancement of differentiation induction of HL-60 cells by 1,25-dihydroxyvitamin D3 in combination with carnosic acid].
An, HP; Chen, JJ; Ren, LH, 2008
)
0.35

Bioavailability

ExcerptReferenceRelevance
" This method was successfully used to study the pharmacokinetics and bioavailability of CA in rats."( High-performance liquid chromatography method for determination of carnosic acid in rat plasma and its application to pharmacokinetic study.
Jiang, Y; Li, X; Lu, W; Tu, P; Wang, L; Wu, L; Yan, H; Yu, C; Zhang, K, 2009
)
0.35
" The bioavailability of carnosic acid, after 360 min, was 40."( Absorption, distribution and elimination of carnosic acid, a natural antioxidant from Rosmarinus officinalis, in rats.
De Smet, S; De Vos, F; Doolaege, EH; Raes, K; Verhé, R, 2011
)
0.37
" The aim of this study was to investigate the bioavailability of these compounds in a rat model of obesity."( Bioavailability of the major bioactive diterpenoids in a rosemary extract: metabolic profile in the intestine, liver, plasma, and brain of Zucker rats.
Espín, JC; Flanagan, J; Fromentin, E; García Villalba, R; García-Conesa, MT; Larrosa, M; Roller, M; Romo Vaquero, M; Tomás-Barberán, FA; Yáñez-Gascón, MJ, 2013
)
0.39
" Nanoparticulate drug delivery systems have been known to better the bioavailability of drugs on intranasal administration compared with only drug solutions."( Carnosic acid nanoparticles suppress liver ischemia/reperfusion injury by inhibition of ROS, Caspases and NF-κB signaling pathway in mice.
Chen, GY; Li, H; Sun, JJ; Tang, GF; Wang, WW; Wei, SD; Xie, ZT, 2016
)
0.43
"The digestion, absorption, uptake and bioavailability of a rosemary supercritical fluid extract encapsulated in oil in water emulsion were studied."( In vitro uptake and immune functionality of digested Rosemary extract delivered through food grade vehicles.
Arranz, E; Corredig, M; Fornari, T; Guri, A; Mendiola, JA; Reglero, G, 2017
)
0.46
" In order to address these issues, we encapsulated CA in a lecithin-based nanoemulsion (CA-NE) to improve its bioaccessibility and bioavailability which are evaluated using in vitro and in vivo digestion models."( Improving the bioaccessibility and bioavailability of carnosic acid using a lecithin-based nanoemulsion: complementary
Cao, Y; Feng, K; Huang, Q; Liu, Q; Wijaya, W; Yin, Z; Zhang, H; Zheng, H; Zheng, T, 2020
)
0.56
" Sulfobutyl ether-beta-cyclodextrin (SBEβCD) was used as the encapsulation agent for the CA-loaded nanocarrier to overcome the poor water solubility and enhance the brain bioavailability of CA."( Inhibition of the CEBPβ-NFκB interaction by nanocarrier-packaged Carnosic acid ameliorates glia-mediated neuroinflammation and improves cognitive function in an Alzheimer's disease model.
Bing, Y; Chun-Yan, W; Fei-Tong, J; Le, K; Minghong, W; Ping, S; Qi, Z; Xiang, L; Xiangxiang, Z; Yan, L; Ye, X; Yi-Bin, W; Yufei, G, 2022
)
0.72

Dosage Studied

ExcerptRelevanceReference
"50 μg/mL dosage prepared from the SC-CO(2) extract."( Anti-inflammatory effects of supercritical carbon dioxide extract and its isolated carnosic acid from Rosmarinus officinalis leaves.
Chang, CH; Chiu, CH; Chyau, CC; Huang, SH; Kuo, CF; Lee, WC; Peng, CC; Su, JD; Sung, TY, 2011
)
0.37
" The results show that CA was more effective in restraining pine nut oil oxidation under heating, UV-A and UV-B radiation, in which a dose-response relationship was observed."( Effects of heat and ultraviolet radiation on the oxidative stability of pine nut oil supplemented with carnosic acid.
Wang, H; Wang, HZ; Yang, L; Zhang, L; Zhang, Y; Zhang, ZH; Zu, G; Zu, YG, 2011
)
0.37
"05) the thiobarbituric acid reactive substances (TBARS) by 39%-47% and 37%-40% in cooked buffalo meat and chicken patties at lower dosage (22."( Relationship between the solubility, dosage and antioxidant capacity of carnosic acid in raw and cooked ground buffalo meat patties and chicken patties.
Chandran, KR; Kiran, M; Kumar, YP; Muthukumar, M; Naveena, BM; Sen, AR; Shaju, VA; Vaithiyanathan, S, 2013
)
0.39
" In the presence of 50 μM of RA, dose-response for CA shifted to IC50 value of 11."( Rosmarinic acid potentiates carnosic acid induced apoptosis in lung fibroblasts.
Bahri, S; Ben Ali, R; Jameleddine, S; Mc Entee, K; Mies, F; Mlika, M; Shlyonsky, V, 2017
)
0.46
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (8)

RoleDescription
antineoplastic agentA substance that inhibits or prevents the proliferation of neoplasms.
antioxidantA substance that opposes oxidation or inhibits reactions brought about by dioxygen or peroxides.
HIV protease inhibitorAn inhibitor of HIV protease, an enzyme required for production of proteins needed for viral assembly.
angiogenesis modulating agentAn agent that modulates the physiologic angiogenesis process. This is accomplished by endogenous angiogenic proteins and a variety of other chemicals and pharmaceutical agents.
apoptosis inducerAny substance that induces the process of apoptosis (programmed cell death) in multi-celled organisms.
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
anti-inflammatory agentAny compound that has anti-inflammatory effects.
food preservativeSubstances which are added to food in order to prevent decomposition caused by microbial growth or by undesirable chemical changes.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (4)

ClassDescription
abietane diterpenoidA diterpenoid based on an abietane skeleton.
carbotricyclic compoundA carbopolyclic compound comprising of three carbocyclic rings.
catecholsAny compound containing an o-diphenol component.
monocarboxylic acidAn oxoacid containing a single carboxy group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (23)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, Putative fructose-1,6-bisphosphate aldolaseGiardia intestinalisPotency9.97630.140911.194039.8107AID2451
Chain A, Ferritin light chainEquus caballus (horse)Potency25.11895.623417.292931.6228AID485281
phosphopantetheinyl transferaseBacillus subtilisPotency2.02620.141337.9142100.0000AID1490; AID2701
Microtubule-associated protein tauHomo sapiens (human)Potency12.06270.180013.557439.8107AID1460; AID1468
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency14.12540.011212.4002100.0000AID1030
euchromatic histone-lysine N-methyltransferase 2Homo sapiens (human)Potency3.54810.035520.977089.1251AID504332
polyunsaturated fatty acid lipoxygenase ALOX12Homo sapiens (human)Potency1.99531.000012.232631.6228AID1452
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1Homo sapiens (human)Potency15.84890.001815.663839.8107AID894
vitamin D3 receptor isoform VDRAHomo sapiens (human)Potency19.95260.354828.065989.1251AID504847
nuclear receptor ROR-gamma isoform 1Mus musculus (house mouse)Potency25.66510.00798.23321,122.0200AID2546; AID2551
Polyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)Potency0.35480.316212.765731.6228AID881
Histamine H2 receptorCavia porcellus (domestic guinea pig)Potency0.35480.00638.235039.8107AID881
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
B-cell CLL/lymphoma 9 proteinHomo sapiens (human)IC50 (µMol)5.21305.21305.21305.2130AID1619715
B-cell CLL/lymphoma 9 proteinHomo sapiens (human)Ki4.87803.00004.87806.3340AID1308849; AID1619686; AID1850535
Prostaglandin E synthaseHomo sapiens (human)IC50 (µMol)5.00000.00102.030810.0000AID1357408
Cytochrome P450 3A4Homo sapiens (human)Ki4.30000.00011.41629.9000AID1209445
Cytochrome P450 2C9 Homo sapiens (human)Ki9.20000.00031.684210.0000AID1209440
Farnesyl pyrophosphate synthaseHomo sapiens (human)IC50 (µMol)20.00000.00020.71099.3600AID1617557
Pancreatic triacylglycerol lipaseHomo sapiens (human)IC50 (µMol)36.00000.00600.32530.7800AID311041
Catenin beta-1Homo sapiens (human)IC50 (µMol)5.21300.80007.668810.0000AID1619715
Catenin beta-1Homo sapiens (human)Ki4.87803.00005.05936.3340AID1308849; AID1619686; AID1850535
Glutathione S-transferase omega-1Homo sapiens (human)IC50 (µMol)62.00000.02801.60404.6000AID1384568
Transcription factor 7-like 2Homo sapiens (human)Ki387.20003.70005.92508.3000AID1619687
Protease Human immunodeficiency virus 1IC50 (µMol)0.24000.00000.81769.8500AID471764
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (261)

Processvia Protein(s)Taxonomy
regulation of transforming growth factor beta receptor signaling pathwayB-cell CLL/lymphoma 9 proteinHomo sapiens (human)
transcription by RNA polymerase IIB-cell CLL/lymphoma 9 proteinHomo sapiens (human)
myotube differentiation involved in skeletal muscle regenerationB-cell CLL/lymphoma 9 proteinHomo sapiens (human)
somatic stem cell population maintenanceB-cell CLL/lymphoma 9 proteinHomo sapiens (human)
skeletal muscle cell differentiationB-cell CLL/lymphoma 9 proteinHomo sapiens (human)
myoblast differentiationB-cell CLL/lymphoma 9 proteinHomo sapiens (human)
canonical Wnt signaling pathwayB-cell CLL/lymphoma 9 proteinHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIB-cell CLL/lymphoma 9 proteinHomo sapiens (human)
prostaglandin biosynthetic processProstaglandin E synthaseHomo sapiens (human)
prostaglandin metabolic processProstaglandin E synthaseHomo sapiens (human)
signal transductionProstaglandin E synthaseHomo sapiens (human)
cell population proliferationProstaglandin E synthaseHomo sapiens (human)
negative regulation of cell population proliferationProstaglandin E synthaseHomo sapiens (human)
sensory perception of painProstaglandin E synthaseHomo sapiens (human)
regulation of fever generationProstaglandin E synthaseHomo sapiens (human)
positive regulation of prostaglandin secretionProstaglandin E synthaseHomo sapiens (human)
regulation of inflammatory responseProstaglandin E synthaseHomo sapiens (human)
cellular oxidant detoxificationProstaglandin E synthaseHomo sapiens (human)
lipid metabolic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
phospholipid metabolic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
apoptotic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
negative regulation of cell population proliferationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
positive regulation of macrophage derived foam cell differentiationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
arachidonic acid metabolic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
negative regulation of cell migrationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
prostate gland developmentPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
regulation of epithelial cell differentiationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
positive regulation of chemokine productionPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
positive regulation of peroxisome proliferator activated receptor signaling pathwayPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
positive regulation of keratinocyte differentiationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
negative regulation of cell cyclePolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
negative regulation of growthPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
hepoxilin biosynthetic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
endocannabinoid signaling pathwayPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
cannabinoid biosynthetic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
lipoxin A4 biosynthetic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
linoleic acid metabolic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
lipid oxidationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
lipoxygenase pathwayPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
lipid hydroxylationCytochrome P450 3A4Homo sapiens (human)
lipid metabolic processCytochrome P450 3A4Homo sapiens (human)
steroid catabolic processCytochrome P450 3A4Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 3A4Homo sapiens (human)
steroid metabolic processCytochrome P450 3A4Homo sapiens (human)
cholesterol metabolic processCytochrome P450 3A4Homo sapiens (human)
androgen metabolic processCytochrome P450 3A4Homo sapiens (human)
estrogen metabolic processCytochrome P450 3A4Homo sapiens (human)
alkaloid catabolic processCytochrome P450 3A4Homo sapiens (human)
monoterpenoid metabolic processCytochrome P450 3A4Homo sapiens (human)
calcitriol biosynthetic process from calciolCytochrome P450 3A4Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 3A4Homo sapiens (human)
vitamin D metabolic processCytochrome P450 3A4Homo sapiens (human)
vitamin D catabolic processCytochrome P450 3A4Homo sapiens (human)
retinol metabolic processCytochrome P450 3A4Homo sapiens (human)
retinoic acid metabolic processCytochrome P450 3A4Homo sapiens (human)
long-chain fatty acid biosynthetic processCytochrome P450 3A4Homo sapiens (human)
aflatoxin metabolic processCytochrome P450 3A4Homo sapiens (human)
oxidative demethylationCytochrome P450 3A4Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 2C9 Homo sapiens (human)
steroid metabolic processCytochrome P450 2C9 Homo sapiens (human)
cholesterol metabolic processCytochrome P450 2C9 Homo sapiens (human)
estrogen metabolic processCytochrome P450 2C9 Homo sapiens (human)
monoterpenoid metabolic processCytochrome P450 2C9 Homo sapiens (human)
epoxygenase P450 pathwayCytochrome P450 2C9 Homo sapiens (human)
urea metabolic processCytochrome P450 2C9 Homo sapiens (human)
monocarboxylic acid metabolic processCytochrome P450 2C9 Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 2C9 Homo sapiens (human)
long-chain fatty acid biosynthetic processCytochrome P450 2C9 Homo sapiens (human)
amide metabolic processCytochrome P450 2C9 Homo sapiens (human)
icosanoid biosynthetic processCytochrome P450 2C9 Homo sapiens (human)
oxidative demethylationCytochrome P450 2C9 Homo sapiens (human)
omega-hydroxylase P450 pathwayCytochrome P450 2C9 Homo sapiens (human)
homophilic cell adhesion via plasma membrane adhesion moleculesCadherin-1Homo sapiens (human)
response to xenobiotic stimulusCadherin-1Homo sapiens (human)
response to toxic substanceCadherin-1Homo sapiens (human)
regulation of gene expressionCadherin-1Homo sapiens (human)
pituitary gland developmentCadherin-1Homo sapiens (human)
negative regulation of cell-cell adhesionCadherin-1Homo sapiens (human)
negative regulation of cell migrationCadherin-1Homo sapiens (human)
negative regulation of axon extensionCadherin-1Homo sapiens (human)
neuron projection developmentCadherin-1Homo sapiens (human)
adherens junction organizationCadherin-1Homo sapiens (human)
positive regulation of protein import into nucleusCadherin-1Homo sapiens (human)
positive regulation of DNA-templated transcriptionCadherin-1Homo sapiens (human)
cellular response to lithium ionCadherin-1Homo sapiens (human)
cellular response to indole-3-methanolCadherin-1Homo sapiens (human)
protein localization to plasma membraneCadherin-1Homo sapiens (human)
cell-cell adhesionCadherin-1Homo sapiens (human)
regulation of protein catabolic process at postsynapse, modulating synaptic transmissionCadherin-1Homo sapiens (human)
response to Gram-positive bacteriumCadherin-1Homo sapiens (human)
cell-cell junction assemblyCadherin-1Homo sapiens (human)
synapse assemblyCadherin-1Homo sapiens (human)
cell-cell adhesion mediated by cadherinCadherin-1Homo sapiens (human)
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion moleculesCadherin-1Homo sapiens (human)
cell morphogenesisCadherin-1Homo sapiens (human)
cell migrationCadherin-1Homo sapiens (human)
multicellular organism developmentCadherin-1Homo sapiens (human)
cholesterol biosynthetic processFarnesyl pyrophosphate synthaseHomo sapiens (human)
geranyl diphosphate biosynthetic processFarnesyl pyrophosphate synthaseHomo sapiens (human)
farnesyl diphosphate biosynthetic processFarnesyl pyrophosphate synthaseHomo sapiens (human)
lipid metabolic processPancreatic triacylglycerol lipaseHomo sapiens (human)
intestinal cholesterol absorptionPancreatic triacylglycerol lipaseHomo sapiens (human)
retinol metabolic processPancreatic triacylglycerol lipaseHomo sapiens (human)
positive regulation of triglyceride lipase activityPancreatic triacylglycerol lipaseHomo sapiens (human)
lipid catabolic processPancreatic triacylglycerol lipaseHomo sapiens (human)
positive regulation of telomere maintenance via telomeraseCatenin beta-1Homo sapiens (human)
negative regulation of apoptotic processCatenin beta-1Homo sapiens (human)
positive regulation of epithelial to mesenchymal transitionCatenin beta-1Homo sapiens (human)
negative regulation of transcription by RNA polymerase IICatenin beta-1Homo sapiens (human)
MAPK cascadeCatenin beta-1Homo sapiens (human)
protein polyubiquitinationCatenin beta-1Homo sapiens (human)
embryonic axis specificationCatenin beta-1Homo sapiens (human)
branching involved in blood vessel morphogenesisCatenin beta-1Homo sapiens (human)
osteoblast differentiationCatenin beta-1Homo sapiens (human)
branching involved in ureteric bud morphogenesisCatenin beta-1Homo sapiens (human)
in utero embryonic developmentCatenin beta-1Homo sapiens (human)
gastrulation with mouth forming secondCatenin beta-1Homo sapiens (human)
cell fate specificationCatenin beta-1Homo sapiens (human)
endodermal cell fate commitmentCatenin beta-1Homo sapiens (human)
neuron migrationCatenin beta-1Homo sapiens (human)
epithelial to mesenchymal transitionCatenin beta-1Homo sapiens (human)
neural plate developmentCatenin beta-1Homo sapiens (human)
positive regulation of neuroblast proliferationCatenin beta-1Homo sapiens (human)
positive regulation of mesenchymal cell proliferationCatenin beta-1Homo sapiens (human)
chondrocyte differentiationCatenin beta-1Homo sapiens (human)
lens morphogenesis in camera-type eyeCatenin beta-1Homo sapiens (human)
outflow tract morphogenesisCatenin beta-1Homo sapiens (human)
regulation of secondary heart field cardioblast proliferationCatenin beta-1Homo sapiens (human)
metanephros morphogenesisCatenin beta-1Homo sapiens (human)
negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesisCatenin beta-1Homo sapiens (human)
transcription by RNA polymerase IICatenin beta-1Homo sapiens (human)
cell adhesionCatenin beta-1Homo sapiens (human)
cell-matrix adhesionCatenin beta-1Homo sapiens (human)
chemical synaptic transmissionCatenin beta-1Homo sapiens (human)
ectoderm developmentCatenin beta-1Homo sapiens (human)
glial cell fate determinationCatenin beta-1Homo sapiens (human)
neuroblast proliferationCatenin beta-1Homo sapiens (human)
positive regulation of cell population proliferationCatenin beta-1Homo sapiens (human)
negative regulation of cell population proliferationCatenin beta-1Homo sapiens (human)
fibroblast growth factor receptor signaling pathwayCatenin beta-1Homo sapiens (human)
response to xenobiotic stimulusCatenin beta-1Homo sapiens (human)
anterior/posterior axis specificationCatenin beta-1Homo sapiens (human)
dorsal/ventral axis specificationCatenin beta-1Homo sapiens (human)
proximal/distal pattern formationCatenin beta-1Homo sapiens (human)
positive regulation of gene expressionCatenin beta-1Homo sapiens (human)
negative regulation of gene expressionCatenin beta-1Homo sapiens (human)
positive regulation of epithelial to mesenchymal transitionCatenin beta-1Homo sapiens (human)
positive regulation of heparan sulfate proteoglycan biosynthetic processCatenin beta-1Homo sapiens (human)
negative regulation of angiogenesisCatenin beta-1Homo sapiens (human)
stem cell population maintenanceCatenin beta-1Homo sapiens (human)
layer formation in cerebral cortexCatenin beta-1Homo sapiens (human)
hypothalamus developmentCatenin beta-1Homo sapiens (human)
central nervous system vasculogenesisCatenin beta-1Homo sapiens (human)
osteoclast differentiationCatenin beta-1Homo sapiens (human)
male genitalia developmentCatenin beta-1Homo sapiens (human)
hindbrain developmentCatenin beta-1Homo sapiens (human)
regulation of centriole-centriole cohesionCatenin beta-1Homo sapiens (human)
pancreas developmentCatenin beta-1Homo sapiens (human)
hair follicle morphogenesisCatenin beta-1Homo sapiens (human)
regulation of protein ubiquitinationCatenin beta-1Homo sapiens (human)
regulation of myelinationCatenin beta-1Homo sapiens (human)
negative regulation of chondrocyte differentiationCatenin beta-1Homo sapiens (human)
response to estradiolCatenin beta-1Homo sapiens (human)
positive regulation of transcription elongation by RNA polymerase IICatenin beta-1Homo sapiens (human)
T cell differentiation in thymusCatenin beta-1Homo sapiens (human)
negative regulation of protein sumoylationCatenin beta-1Homo sapiens (human)
adherens junction assemblyCatenin beta-1Homo sapiens (human)
protein localization to cell surfaceCatenin beta-1Homo sapiens (human)
embryonic heart tube developmentCatenin beta-1Homo sapiens (human)
genitalia morphogenesisCatenin beta-1Homo sapiens (human)
embryonic forelimb morphogenesisCatenin beta-1Homo sapiens (human)
embryonic hindlimb morphogenesisCatenin beta-1Homo sapiens (human)
hair cell differentiationCatenin beta-1Homo sapiens (human)
detection of muscle stretchCatenin beta-1Homo sapiens (human)
embryonic skeletal limb joint morphogenesisCatenin beta-1Homo sapiens (human)
astrocyte-dopaminergic neuron signalingCatenin beta-1Homo sapiens (human)
regulation of T cell proliferationCatenin beta-1Homo sapiens (human)
odontogenesis of dentin-containing toothCatenin beta-1Homo sapiens (human)
embryonic digit morphogenesisCatenin beta-1Homo sapiens (human)
positive regulation of apoptotic processCatenin beta-1Homo sapiens (human)
negative regulation of apoptotic processCatenin beta-1Homo sapiens (human)
proteasome-mediated ubiquitin-dependent protein catabolic processCatenin beta-1Homo sapiens (human)
positive regulation of MAPK cascadeCatenin beta-1Homo sapiens (human)
positive regulation of neuron apoptotic processCatenin beta-1Homo sapiens (human)
canonical Wnt signaling pathway involved in mesenchymal stem cell differentiationCatenin beta-1Homo sapiens (human)
bone resorptionCatenin beta-1Homo sapiens (human)
positive regulation of cell differentiationCatenin beta-1Homo sapiens (human)
positive regulation of endothelial cell differentiationCatenin beta-1Homo sapiens (human)
positive regulation of osteoblast differentiationCatenin beta-1Homo sapiens (human)
negative regulation of osteoclast differentiationCatenin beta-1Homo sapiens (human)
positive regulation of fibroblast growth factor receptor signaling pathwayCatenin beta-1Homo sapiens (human)
regulation of angiogenesisCatenin beta-1Homo sapiens (human)
negative regulation of DNA-templated transcriptionCatenin beta-1Homo sapiens (human)
positive regulation of DNA-templated transcriptionCatenin beta-1Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICatenin beta-1Homo sapiens (human)
negative regulation of mitotic cell cycle, embryonicCatenin beta-1Homo sapiens (human)
regulation of fibroblast proliferationCatenin beta-1Homo sapiens (human)
cell maturationCatenin beta-1Homo sapiens (human)
synaptic vesicle transportCatenin beta-1Homo sapiens (human)
thymus developmentCatenin beta-1Homo sapiens (human)
oocyte developmentCatenin beta-1Homo sapiens (human)
embryonic foregut morphogenesisCatenin beta-1Homo sapiens (human)
positive regulation of skeletal muscle tissue developmentCatenin beta-1Homo sapiens (human)
regulation of smooth muscle cell proliferationCatenin beta-1Homo sapiens (human)
neuron fate determinationCatenin beta-1Homo sapiens (human)
oligodendrocyte differentiationCatenin beta-1Homo sapiens (human)
negative regulation of oligodendrocyte differentiationCatenin beta-1Homo sapiens (human)
regulation of neurogenesisCatenin beta-1Homo sapiens (human)
synapse organizationCatenin beta-1Homo sapiens (human)
smooth muscle cell differentiationCatenin beta-1Homo sapiens (human)
myoblast proliferationCatenin beta-1Homo sapiens (human)
regulation of timing of anagenCatenin beta-1Homo sapiens (human)
regulation of synapse assemblyCatenin beta-1Homo sapiens (human)
oviduct developmentCatenin beta-1Homo sapiens (human)
canonical Wnt signaling pathwayCatenin beta-1Homo sapiens (human)
trachea formationCatenin beta-1Homo sapiens (human)
epithelial tube branching involved in lung morphogenesisCatenin beta-1Homo sapiens (human)
lung-associated mesenchyme developmentCatenin beta-1Homo sapiens (human)
lung epithelial cell differentiationCatenin beta-1Homo sapiens (human)
lung inductionCatenin beta-1Homo sapiens (human)
epithelial cell differentiation involved in prostate gland developmentCatenin beta-1Homo sapiens (human)
epithelial cell proliferation involved in prostate gland developmentCatenin beta-1Homo sapiens (human)
positive regulation of epithelial cell proliferation involved in prostate gland developmentCatenin beta-1Homo sapiens (human)
hair follicle placode formationCatenin beta-1Homo sapiens (human)
establishment of blood-brain barrierCatenin beta-1Homo sapiens (human)
mesenchymal cell proliferation involved in lung developmentCatenin beta-1Homo sapiens (human)
positive regulation of branching involved in lung morphogenesisCatenin beta-1Homo sapiens (human)
endothelial tube morphogenesisCatenin beta-1Homo sapiens (human)
fungiform papilla formationCatenin beta-1Homo sapiens (human)
sympathetic ganglion developmentCatenin beta-1Homo sapiens (human)
cranial ganglion developmentCatenin beta-1Homo sapiens (human)
regulation of centromeric sister chromatid cohesionCatenin beta-1Homo sapiens (human)
cellular response to growth factor stimulusCatenin beta-1Homo sapiens (human)
cellular response to indole-3-methanolCatenin beta-1Homo sapiens (human)
renal vesicle formationCatenin beta-1Homo sapiens (human)
renal inner medulla developmentCatenin beta-1Homo sapiens (human)
renal outer medulla developmentCatenin beta-1Homo sapiens (human)
nephron tubule formationCatenin beta-1Homo sapiens (human)
stem cell proliferationCatenin beta-1Homo sapiens (human)
regulation of nephron tubule epithelial cell differentiationCatenin beta-1Homo sapiens (human)
mesenchymal stem cell differentiationCatenin beta-1Homo sapiens (human)
negative regulation of canonical Wnt signaling pathwayCatenin beta-1Homo sapiens (human)
regulation of calcium ion importCatenin beta-1Homo sapiens (human)
acinar cell differentiationCatenin beta-1Homo sapiens (human)
synaptic vesicle clusteringCatenin beta-1Homo sapiens (human)
apoptotic signaling pathwayCatenin beta-1Homo sapiens (human)
cell-cell adhesionCatenin beta-1Homo sapiens (human)
positive regulation of odontoblast differentiationCatenin beta-1Homo sapiens (human)
negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathwayCatenin beta-1Homo sapiens (human)
cranial skeletal system developmentCatenin beta-1Homo sapiens (human)
midbrain dopaminergic neuron differentiationCatenin beta-1Homo sapiens (human)
neuron projection extensionCatenin beta-1Homo sapiens (human)
embryonic brain developmentCatenin beta-1Homo sapiens (human)
dorsal root ganglion developmentCatenin beta-1Homo sapiens (human)
establishment of blood-retinal barrierCatenin beta-1Homo sapiens (human)
regulation of protein localization to cell surfaceCatenin beta-1Homo sapiens (human)
positive regulation of determination of dorsal identityCatenin beta-1Homo sapiens (human)
positive regulation of myoblast proliferationCatenin beta-1Homo sapiens (human)
positive regulation of stem cell proliferationCatenin beta-1Homo sapiens (human)
regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulumGlutathione S-transferase omega-1Homo sapiens (human)
regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ionGlutathione S-transferase omega-1Homo sapiens (human)
positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ionGlutathione S-transferase omega-1Homo sapiens (human)
L-ascorbic acid metabolic processGlutathione S-transferase omega-1Homo sapiens (human)
xenobiotic catabolic processGlutathione S-transferase omega-1Homo sapiens (human)
negative regulation of ryanodine-sensitive calcium-release channel activityGlutathione S-transferase omega-1Homo sapiens (human)
positive regulation of ryanodine-sensitive calcium-release channel activityGlutathione S-transferase omega-1Homo sapiens (human)
cellular response to arsenic-containing substanceGlutathione S-transferase omega-1Homo sapiens (human)
cellular oxidant detoxificationGlutathione S-transferase omega-1Homo sapiens (human)
glutathione metabolic processGlutathione S-transferase omega-1Homo sapiens (human)
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionTranscription factor 7-like 2Homo sapiens (human)
negative regulation of transcription by RNA polymerase IITranscription factor 7-like 2Homo sapiens (human)
blood vessel developmentTranscription factor 7-like 2Homo sapiens (human)
regulation of transcription by RNA polymerase IITranscription factor 7-like 2Homo sapiens (human)
response to glucoseTranscription factor 7-like 2Homo sapiens (human)
positive regulation of epithelial to mesenchymal transitionTranscription factor 7-like 2Homo sapiens (human)
positive regulation of heparan sulfate proteoglycan biosynthetic processTranscription factor 7-like 2Homo sapiens (human)
pancreas developmentTranscription factor 7-like 2Homo sapiens (human)
positive regulation of insulin secretionTranscription factor 7-like 2Homo sapiens (human)
positive regulation of protein bindingTranscription factor 7-like 2Homo sapiens (human)
regulation of hormone metabolic processTranscription factor 7-like 2Homo sapiens (human)
glucose homeostasisTranscription factor 7-like 2Homo sapiens (human)
negative regulation of DNA-binding transcription factor activityTranscription factor 7-like 2Homo sapiens (human)
maintenance of DNA repeat elementsTranscription factor 7-like 2Homo sapiens (human)
fat cell differentiationTranscription factor 7-like 2Homo sapiens (human)
negative regulation of gluconeogenesisTranscription factor 7-like 2Homo sapiens (human)
negative regulation of DNA-templated transcriptionTranscription factor 7-like 2Homo sapiens (human)
positive regulation of transcription by RNA polymerase IITranscription factor 7-like 2Homo sapiens (human)
myoblast fate commitmentTranscription factor 7-like 2Homo sapiens (human)
regulation of smooth muscle cell proliferationTranscription factor 7-like 2Homo sapiens (human)
positive regulation of epithelial cell proliferationTranscription factor 7-like 2Homo sapiens (human)
canonical Wnt signaling pathwayTranscription factor 7-like 2Homo sapiens (human)
negative regulation of canonical Wnt signaling pathwayTranscription factor 7-like 2Homo sapiens (human)
positive regulation of protein localization to nucleusTranscription factor 7-like 2Homo sapiens (human)
negative regulation of type B pancreatic cell apoptotic processTranscription factor 7-like 2Homo sapiens (human)
negative regulation of extrinsic apoptotic signaling pathwayTranscription factor 7-like 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (83)

Processvia Protein(s)Taxonomy
transcription coactivator activityB-cell CLL/lymphoma 9 proteinHomo sapiens (human)
protein bindingB-cell CLL/lymphoma 9 proteinHomo sapiens (human)
beta-catenin bindingB-cell CLL/lymphoma 9 proteinHomo sapiens (human)
glutathione transferase activityProstaglandin E synthaseHomo sapiens (human)
glutathione peroxidase activityProstaglandin E synthaseHomo sapiens (human)
prostaglandin-D synthase activityProstaglandin E synthaseHomo sapiens (human)
protein bindingProstaglandin E synthaseHomo sapiens (human)
glutathione bindingProstaglandin E synthaseHomo sapiens (human)
prostaglandin-E synthase activityProstaglandin E synthaseHomo sapiens (human)
iron ion bindingPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
calcium ion bindingPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
protein bindingPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
lipid bindingPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
linoleate 13S-lipoxygenase activityPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
arachidonate 8(S)-lipoxygenase activityPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
arachidonate 15-lipoxygenase activityPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
linoleate 9S-lipoxygenase activityPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
monooxygenase activityCytochrome P450 3A4Homo sapiens (human)
steroid bindingCytochrome P450 3A4Homo sapiens (human)
iron ion bindingCytochrome P450 3A4Homo sapiens (human)
protein bindingCytochrome P450 3A4Homo sapiens (human)
steroid hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
retinoic acid 4-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
oxidoreductase activityCytochrome P450 3A4Homo sapiens (human)
oxygen bindingCytochrome P450 3A4Homo sapiens (human)
enzyme bindingCytochrome P450 3A4Homo sapiens (human)
heme bindingCytochrome P450 3A4Homo sapiens (human)
vitamin D3 25-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
caffeine oxidase activityCytochrome P450 3A4Homo sapiens (human)
quinine 3-monooxygenase activityCytochrome P450 3A4Homo sapiens (human)
testosterone 6-beta-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
anandamide 8,9 epoxidase activityCytochrome P450 3A4Homo sapiens (human)
anandamide 11,12 epoxidase activityCytochrome P450 3A4Homo sapiens (human)
anandamide 14,15 epoxidase activityCytochrome P450 3A4Homo sapiens (human)
aromatase activityCytochrome P450 3A4Homo sapiens (human)
vitamin D 24-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
estrogen 16-alpha-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
estrogen 2-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
1,8-cineole 2-exo-monooxygenase activityCytochrome P450 3A4Homo sapiens (human)
monooxygenase activityCytochrome P450 2C9 Homo sapiens (human)
iron ion bindingCytochrome P450 2C9 Homo sapiens (human)
arachidonic acid epoxygenase activityCytochrome P450 2C9 Homo sapiens (human)
steroid hydroxylase activityCytochrome P450 2C9 Homo sapiens (human)
arachidonic acid 14,15-epoxygenase activityCytochrome P450 2C9 Homo sapiens (human)
arachidonic acid 11,12-epoxygenase activityCytochrome P450 2C9 Homo sapiens (human)
oxidoreductase activityCytochrome P450 2C9 Homo sapiens (human)
(S)-limonene 6-monooxygenase activityCytochrome P450 2C9 Homo sapiens (human)
(S)-limonene 7-monooxygenase activityCytochrome P450 2C9 Homo sapiens (human)
caffeine oxidase activityCytochrome P450 2C9 Homo sapiens (human)
(R)-limonene 6-monooxygenase activityCytochrome P450 2C9 Homo sapiens (human)
aromatase activityCytochrome P450 2C9 Homo sapiens (human)
heme bindingCytochrome P450 2C9 Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenCytochrome P450 2C9 Homo sapiens (human)
calcium ion bindingCadherin-1Homo sapiens (human)
protein bindingCadherin-1Homo sapiens (human)
beta-catenin bindingCadherin-1Homo sapiens (human)
ankyrin bindingCadherin-1Homo sapiens (human)
GTPase activating protein bindingCadherin-1Homo sapiens (human)
identical protein bindingCadherin-1Homo sapiens (human)
gamma-catenin bindingCadherin-1Homo sapiens (human)
cadherin bindingCadherin-1Homo sapiens (human)
cell adhesion molecule bindingCadherin-1Homo sapiens (human)
protein tyrosine kinase bindingCadherin-1Homo sapiens (human)
RNA bindingFarnesyl pyrophosphate synthaseHomo sapiens (human)
protein bindingFarnesyl pyrophosphate synthaseHomo sapiens (human)
metal ion bindingFarnesyl pyrophosphate synthaseHomo sapiens (human)
dimethylallyltranstransferase activityFarnesyl pyrophosphate synthaseHomo sapiens (human)
geranyltranstransferase activityFarnesyl pyrophosphate synthaseHomo sapiens (human)
triglyceride lipase activityPancreatic triacylglycerol lipaseHomo sapiens (human)
lipase activityPancreatic triacylglycerol lipaseHomo sapiens (human)
metal ion bindingPancreatic triacylglycerol lipaseHomo sapiens (human)
all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activityPancreatic triacylglycerol lipaseHomo sapiens (human)
transcription coregulator bindingCatenin beta-1Homo sapiens (human)
transcription corepressor bindingCatenin beta-1Homo sapiens (human)
chromatin bindingCatenin beta-1Homo sapiens (human)
transcription coactivator activityCatenin beta-1Homo sapiens (human)
signaling receptor bindingCatenin beta-1Homo sapiens (human)
protein bindingCatenin beta-1Homo sapiens (human)
nuclear receptor bindingCatenin beta-1Homo sapiens (human)
enzyme bindingCatenin beta-1Homo sapiens (human)
kinase bindingCatenin beta-1Homo sapiens (human)
protein kinase bindingCatenin beta-1Homo sapiens (human)
nuclear estrogen receptor bindingCatenin beta-1Homo sapiens (human)
ubiquitin protein ligase bindingCatenin beta-1Homo sapiens (human)
transmembrane transporter bindingCatenin beta-1Homo sapiens (human)
alpha-catenin bindingCatenin beta-1Homo sapiens (human)
cadherin bindingCatenin beta-1Homo sapiens (human)
SMAD bindingCatenin beta-1Homo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingCatenin beta-1Homo sapiens (human)
I-SMAD bindingCatenin beta-1Homo sapiens (human)
disordered domain specific bindingCatenin beta-1Homo sapiens (human)
DNA-binding transcription factor bindingCatenin beta-1Homo sapiens (human)
protein phosphatase bindingCatenin beta-1Homo sapiens (human)
glutathione transferase activityGlutathione S-transferase omega-1Homo sapiens (human)
protein bindingGlutathione S-transferase omega-1Homo sapiens (human)
oxidoreductase activityGlutathione S-transferase omega-1Homo sapiens (human)
glutathione dehydrogenase (ascorbate) activityGlutathione S-transferase omega-1Homo sapiens (human)
methylarsonate reductase activityGlutathione S-transferase omega-1Homo sapiens (human)
transcription cis-regulatory region bindingTranscription factor 7-like 2Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingTranscription factor 7-like 2Homo sapiens (human)
DNA-binding transcription factor activityTranscription factor 7-like 2Homo sapiens (human)
protein bindingTranscription factor 7-like 2Homo sapiens (human)
beta-catenin bindingTranscription factor 7-like 2Homo sapiens (human)
nuclear receptor bindingTranscription factor 7-like 2Homo sapiens (human)
protein kinase bindingTranscription factor 7-like 2Homo sapiens (human)
sequence-specific DNA bindingTranscription factor 7-like 2Homo sapiens (human)
gamma-catenin bindingTranscription factor 7-like 2Homo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingTranscription factor 7-like 2Homo sapiens (human)
armadillo repeat domain bindingTranscription factor 7-like 2Homo sapiens (human)
promoter-specific chromatin bindingTranscription factor 7-like 2Homo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificTranscription factor 7-like 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (62)

Processvia Protein(s)Taxonomy
nucleoplasmB-cell CLL/lymphoma 9 proteinHomo sapiens (human)
cis-Golgi networkB-cell CLL/lymphoma 9 proteinHomo sapiens (human)
sarcoplasmB-cell CLL/lymphoma 9 proteinHomo sapiens (human)
beta-catenin-TCF complexB-cell CLL/lymphoma 9 proteinHomo sapiens (human)
nuclear envelope lumenProstaglandin E synthaseHomo sapiens (human)
endoplasmic reticulum membraneProstaglandin E synthaseHomo sapiens (human)
membraneProstaglandin E synthaseHomo sapiens (human)
perinuclear region of cytoplasmProstaglandin E synthaseHomo sapiens (human)
membraneProstaglandin E synthaseHomo sapiens (human)
nucleusPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
cytosolPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
cytoskeletonPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
plasma membranePolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
adherens junctionPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
focal adhesionPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
membranePolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
extracellular exosomePolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
cytoplasmCytochrome P450 3A4Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 3A4Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 3A4Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 2C9 Homo sapiens (human)
plasma membraneCytochrome P450 2C9 Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 2C9 Homo sapiens (human)
cytoplasmCytochrome P450 2C9 Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 2C9 Homo sapiens (human)
cortical actin cytoskeletonCadherin-1Homo sapiens (human)
extracellular regionCadherin-1Homo sapiens (human)
endosomeCadherin-1Homo sapiens (human)
trans-Golgi networkCadherin-1Homo sapiens (human)
plasma membraneCadherin-1Homo sapiens (human)
adherens junctionCadherin-1Homo sapiens (human)
cytoplasmic side of plasma membraneCadherin-1Homo sapiens (human)
actin cytoskeletonCadherin-1Homo sapiens (human)
membraneCadherin-1Homo sapiens (human)
lateral plasma membraneCadherin-1Homo sapiens (human)
lamellipodiumCadherin-1Homo sapiens (human)
cell junctionCadherin-1Homo sapiens (human)
apical junction complexCadherin-1Homo sapiens (human)
perinuclear region of cytoplasmCadherin-1Homo sapiens (human)
extracellular exosomeCadherin-1Homo sapiens (human)
postsynapseCadherin-1Homo sapiens (human)
glutamatergic synapseCadherin-1Homo sapiens (human)
catenin complexCadherin-1Homo sapiens (human)
flotillin complexCadherin-1Homo sapiens (human)
apical junction complexCadherin-1Homo sapiens (human)
adherens junctionCadherin-1Homo sapiens (human)
nucleoplasmFarnesyl pyrophosphate synthaseHomo sapiens (human)
cytosolFarnesyl pyrophosphate synthaseHomo sapiens (human)
cytoplasmFarnesyl pyrophosphate synthaseHomo sapiens (human)
extracellular regionPancreatic triacylglycerol lipaseHomo sapiens (human)
extracellular spacePancreatic triacylglycerol lipaseHomo sapiens (human)
extracellular spacePancreatic triacylglycerol lipaseHomo sapiens (human)
spindle poleCatenin beta-1Homo sapiens (human)
nucleusCatenin beta-1Homo sapiens (human)
nucleoplasmCatenin beta-1Homo sapiens (human)
cytoplasmCatenin beta-1Homo sapiens (human)
centrosomeCatenin beta-1Homo sapiens (human)
cytosolCatenin beta-1Homo sapiens (human)
plasma membraneCatenin beta-1Homo sapiens (human)
cell-cell junctionCatenin beta-1Homo sapiens (human)
adherens junctionCatenin beta-1Homo sapiens (human)
fascia adherensCatenin beta-1Homo sapiens (human)
bicellular tight junctionCatenin beta-1Homo sapiens (human)
focal adhesionCatenin beta-1Homo sapiens (human)
cell cortexCatenin beta-1Homo sapiens (human)
membraneCatenin beta-1Homo sapiens (human)
basolateral plasma membraneCatenin beta-1Homo sapiens (human)
apicolateral plasma membraneCatenin beta-1Homo sapiens (human)
lateral plasma membraneCatenin beta-1Homo sapiens (human)
Z discCatenin beta-1Homo sapiens (human)
lamellipodiumCatenin beta-1Homo sapiens (human)
cell junctionCatenin beta-1Homo sapiens (human)
microvillus membraneCatenin beta-1Homo sapiens (human)
presynaptic membraneCatenin beta-1Homo sapiens (human)
apical part of cellCatenin beta-1Homo sapiens (human)
synapseCatenin beta-1Homo sapiens (human)
postsynaptic membraneCatenin beta-1Homo sapiens (human)
perinuclear region of cytoplasmCatenin beta-1Homo sapiens (human)
extracellular exosomeCatenin beta-1Homo sapiens (human)
cell peripheryCatenin beta-1Homo sapiens (human)
Schaffer collateral - CA1 synapseCatenin beta-1Homo sapiens (human)
presynaptic active zone cytoplasmic componentCatenin beta-1Homo sapiens (human)
glutamatergic synapseCatenin beta-1Homo sapiens (human)
postsynaptic density, intracellular componentCatenin beta-1Homo sapiens (human)
beta-catenin-TCF complexCatenin beta-1Homo sapiens (human)
euchromatinCatenin beta-1Homo sapiens (human)
transcription regulator complexCatenin beta-1Homo sapiens (human)
catenin complexCatenin beta-1Homo sapiens (human)
flotillin complexCatenin beta-1Homo sapiens (human)
beta-catenin destruction complexCatenin beta-1Homo sapiens (human)
protein-containing complexCatenin beta-1Homo sapiens (human)
protein-DNA complexCatenin beta-1Homo sapiens (human)
Scrib-APC-beta-catenin complexCatenin beta-1Homo sapiens (human)
beta-catenin-TCF7L2 complexCatenin beta-1Homo sapiens (human)
beta-catenin-ICAT complexCatenin beta-1Homo sapiens (human)
Wnt signalosomeCatenin beta-1Homo sapiens (human)
cytoplasmCatenin beta-1Homo sapiens (human)
adherens junctionCatenin beta-1Homo sapiens (human)
nucleusCatenin beta-1Homo sapiens (human)
cytoplasmGlutathione S-transferase omega-1Homo sapiens (human)
cytosolGlutathione S-transferase omega-1Homo sapiens (human)
extracellular exosomeGlutathione S-transferase omega-1Homo sapiens (human)
cytoplasmGlutathione S-transferase omega-1Homo sapiens (human)
nucleusTranscription factor 7-like 2Homo sapiens (human)
nucleoplasmTranscription factor 7-like 2Homo sapiens (human)
PML bodyTranscription factor 7-like 2Homo sapiens (human)
chromatinTranscription factor 7-like 2Homo sapiens (human)
protein-DNA complexTranscription factor 7-like 2Homo sapiens (human)
beta-catenin-TCF7L2 complexTranscription factor 7-like 2Homo sapiens (human)
beta-catenin-TCF complexTranscription factor 7-like 2Homo sapiens (human)
catenin-TCF7L2 complexTranscription factor 7-like 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (77)

Assay IDTitleYearJournalArticle
AID1756075Antibiofilm activity against Staphylococcus aureus ATCC 25923 assessed as inhibition of bacterial metabolism within the biofilm at 4 ug/ml measured after 48 hrs by MTT assay relative to control
AID1209439Time dependent inhibition of CYP3A4 activity in human hepatocytes after 30 mins by liquid chromatography/tandem mass spectroscopy2012Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 40, Issue:7
In vitro hepatotoxicity and cytochrome P450 induction and inhibition characteristics of carnosic acid, a dietary supplement with antiadipogenic properties.
AID1209435Time dependent inhibition of CYP2C9 activity in human hepatocytes after 30 mins by liquid chromatography/tandem mass spectroscopy2012Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 40, Issue:7
In vitro hepatotoxicity and cytochrome P450 induction and inhibition characteristics of carnosic acid, a dietary supplement with antiadipogenic properties.
AID478075Cytotoxicity against human MRC5 cells after 24 hrs by neutral red uptake assay2010Journal of natural products, Apr-23, Volume: 73, Issue:4
Gastroprotective effect of carnosic acid gamma-lactone derivatives.
AID478077Cytotoxicity against human HepG2 cells after 24 hrs by neutral red uptake assay2010Journal of natural products, Apr-23, Volume: 73, Issue:4
Gastroprotective effect of carnosic acid gamma-lactone derivatives.
AID1756064Antibiofilm activity against Acinetobacter baumannii ATCC 19606 assessed as inhibition of biofilm formation at 4 ug/ml measured after 48 hrs by crystal violet staining based assay relative to control
AID1209425Cytotoxicity against human hepatocytes assessed as reduction in cell viability after 24 hrs by ATP detection based assay2012Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 40, Issue:7
In vitro hepatotoxicity and cytochrome P450 induction and inhibition characteristics of carnosic acid, a dietary supplement with antiadipogenic properties.
AID1384568Inhibition of GSTO1-1 (unknown origin) by 4-NPG substrate based assay2018Journal of medicinal chemistry, 09-13, Volume: 61, Issue:17
Reviewing Hit Discovery Literature for Difficult Targets: Glutathione Transferase Omega-1 as an Example.
AID1209444Cytotoxicity against human hepatocytes assessed as reduction in cell viability after 4 hrs by ATP detection based assay2012Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 40, Issue:7
In vitro hepatotoxicity and cytochrome P450 induction and inhibition characteristics of carnosic acid, a dietary supplement with antiadipogenic properties.
AID1756079Antibiofilm activity against Pseudomonas aeruginosa ATCC 50071 assessed as inhibition of bacterial metabolism within the biofilm at 8 ug/ml measured after 48 hrs by MTT assay relative to control
AID1357408Inhibition of mPGES1 in human A549 cell microsomal membrane using pGH2 as substrate pretreated for 15 mins followed by substrate addition and measured after 1 min by RP-HPLC method2018European journal of medicinal chemistry, Jun-10, Volume: 153Plant-derived mPGES-1 inhibitors or suppressors: A new emerging trend in the search for small molecules to combat inflammation.
AID1756072Antibiofilm activity against Escherichia coli DSM 8579 assessed as inhibition of biofilm formation at 80 ug/ml measured after 48 hrs by crystal violet staining based assay relative to control
AID1209440Inhibition of CYP2C9 activity in human hepatocytes after 30 mins by liquid chromatography/tandem mass spectroscopy2012Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 40, Issue:7
In vitro hepatotoxicity and cytochrome P450 induction and inhibition characteristics of carnosic acid, a dietary supplement with antiadipogenic properties.
AID744357Activation of Nrf2/ARE in E15 stage mouse primary cortical neurons after 48 hrs by human placental alkaline phosphatase reporter gene assay2013Bioorganic & medicinal chemistry, May-01, Volume: 21, Issue:9
Structure activity relationship of phenolic diterpenes from Salvia officinalis as activators of the nuclear factor E2-related factor 2 pathway.
AID478076Cytotoxicity against human AGS cells after 24 hrs by neutral red uptake assay2010Journal of natural products, Apr-23, Volume: 73, Issue:4
Gastroprotective effect of carnosic acid gamma-lactone derivatives.
AID1209430Induction of CYP2B6 mRNA expression in human hepatocytes at 10 uM after 48 hrs relative to untreated control2012Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 40, Issue:7
In vitro hepatotoxicity and cytochrome P450 induction and inhibition characteristics of carnosic acid, a dietary supplement with antiadipogenic properties.
AID1209441Cytotoxicity against human hepatocytes assessed as loss of nuclei after 24 hrs at 50 to 100 uM2012Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 40, Issue:7
In vitro hepatotoxicity and cytochrome P450 induction and inhibition characteristics of carnosic acid, a dietary supplement with antiadipogenic properties.
AID1756065Antibiofilm activity against Pectobacterium carotovorum ATCC 15713 assessed as inhibition of biofilm formation at 4 ug/ml measured after 48 hrs by crystal violet staining based assay relative to control
AID389750Inhibition of NorA efflux pump in Staphylococcus aureus 1199 assessed as fold reduction of ciprofloxacin MIC at 25 ug/ml2008Bioorganic & medicinal chemistry, Nov-15, Volume: 16, Issue:22
Piperine analogs as potent Staphylococcus aureus NorA efflux pump inhibitors.
AID1850535Binding affinity to N-terminal FLAG tagged beta catenin (134 to 671 residues)/FLAG tagged BCL9 domain 2 (343 to 396 residues) (unknown origin) protein protein interaction assessed as inhibition constant2022Journal of medicinal chemistry, 05-26, Volume: 65, Issue:10
Biophysical Survey of Small-Molecule β-Catenin Inhibitors: A Cautionary Tale.
AID1209427Cytotoxicity against human hepatocytes assessed as reduction in cell viability after 4 hrs by LDH release assay2012Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 40, Issue:7
In vitro hepatotoxicity and cytochrome P450 induction and inhibition characteristics of carnosic acid, a dietary supplement with antiadipogenic properties.
AID389741Inhibition of NorA efflux pump in Staphylococcus aureus 1199B assessed as fold reduction of ciprofloxacin MIC at 25 ug/ml2008Bioorganic & medicinal chemistry, Nov-15, Volume: 16, Issue:22
Piperine analogs as potent Staphylococcus aureus NorA efflux pump inhibitors.
AID1756070Antibiofilm activity against Pectobacterium carotovorum ATCC 15713 assessed as inhibition of biofilm formation at 8 ug/ml measured after 48 hrs by crystal violet staining based assay relative to control
AID1209438Time dependent inhibition of CYP2E1 activity in human hepatocytes after 30 mins by liquid chromatography/tandem mass spectroscopy2012Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 40, Issue:7
In vitro hepatotoxicity and cytochrome P450 induction and inhibition characteristics of carnosic acid, a dietary supplement with antiadipogenic properties.
AID1209429Induction of CYP3A4 mRNA expression in human hepatocytes at 10 uM after 48 hrs relative to untreated control2012Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 40, Issue:7
In vitro hepatotoxicity and cytochrome P450 induction and inhibition characteristics of carnosic acid, a dietary supplement with antiadipogenic properties.
AID1756077Antibiofilm activity against Pectobacterium carotovorum ATCC 15713 assessed as inhibition of bacterial metabolism within the biofilm at 4 ug/ml measured after 48 hrs by MTT assay relative to control
AID1246300Cytotoxicity against human HepG2 cells at <= 50 uM after 72 hrs by CellTiter-Glo assay2015European journal of medicinal chemistry, Sep-18, Volume: 102(+)-Dehydroabietylamine derivatives target triple-negative breast cancer.
AID1756062Antibiofilm activity against Pseudomonas aeruginosa ATCC 50071 assessed as inhibition of biofilm formation at 4 ug/ml measured after 48 hrs by crystal violet staining based assay relative to control
AID1756082Antibiofilm activity against Pectobacterium carotovorum ATCC 15713 assessed as inhibition of bacterial metabolism within the biofilm at 8 ug/ml measured after 48 hrs by MTT assay relative to control
AID1756061Antibiofilm activity against Listeria monocytogenes ATCC 7644 assessed as inhibition of biofilm formation at 4 ug/ml measured after 48 hrs by crystal violet staining based assay relative to control
AID335102Inhibition of bovine spleen cathepsin D up to 10 ug/ml1993Journal of natural products, Aug, Volume: 56, Issue:8
Inhibitory effect of carnosic acid on HIV-1 protease in cell-free assays [corrected].
AID406529Inhibition of NorA efflux pump in Staphylococcus aureus 1199B assessed as fold reduction of ciprofloxacin MIC at 25 ug/ml2008Bioorganic & medicinal chemistry, Jul-01, Volume: 16, Issue:13
Citral derived amides as potent bacterial NorA efflux pump inhibitors.
AID1209443Cytotoxicity against human hepatocytes assessed as cell viability after 24 hrs at 100 uM by ATP detection based assay2012Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 40, Issue:7
In vitro hepatotoxicity and cytochrome P450 induction and inhibition characteristics of carnosic acid, a dietary supplement with antiadipogenic properties.
AID1617557Inhibition of human N-terminal TEV protease cleavage site-fused-His6-tagged FPPS expressed in Escherichia coli BL21 (DE3) using GPP and IPP as substrate preincubated for 30 mins followed by substrate addition by continuous spectrophotometric assay2019Journal of medicinal chemistry, 12-12, Volume: 62, Issue:23
Farnesyl Pyrophosphate Synthase as a Target for Drug Development: Discovery of Natural-Product-Derived Inhibitors and Their Activity in Pancreatic Cancer Cells.
AID1617556Inhibition of human N-terminal TEV protease cleavage site-fused-His6-tagged GGPPS expressed in Escherichia coli BL21 (DE3) using FPP and [14C] IPP as substrate preincubated for 15 mins with FPP followed by [14C] IPP addition and further incubated for 20 m2019Journal of medicinal chemistry, 12-12, Volume: 62, Issue:23
Farnesyl Pyrophosphate Synthase as a Target for Drug Development: Discovery of Natural-Product-Derived Inhibitors and Their Activity in Pancreatic Cancer Cells.
AID1756078Antibiofilm activity against Listeria monocytogenes ATCC 7644 assessed as inhibition of bacterial metabolism within the biofilm at 8 ug/ml measured after 48 hrs by MTT assay relative to control
AID406536Inhibition of NorA efflux pump in Staphylococcus aureus 1199 assessed as fold reduction of ciprofloxacin MIC at 25 ug/ml2008Bioorganic & medicinal chemistry, Jul-01, Volume: 16, Issue:13
Citral derived amides as potent bacterial NorA efflux pump inhibitors.
AID1756073Antibiofilm activity against Listeria monocytogenes ATCC 7644 assessed as inhibition of bacterial metabolism within the biofilm at 4 ug/ml measured after 48 hrs by MTT assay relative to control
AID311041Inhibition of pancreatic lipase2007Bioorganic & medicinal chemistry, Jul-15, Volume: 15, Issue:14
The biology and chemistry of hyperlipidemia.
AID335104Cytotoxicity against human H9 cells after 3 or 5 days by XTT assay1993Journal of natural products, Aug, Volume: 56, Issue:8
Inhibitory effect of carnosic acid on HIV-1 protease in cell-free assays [corrected].
AID1209445Inhibition of CYP3A4 activity in human hepatocytes after 30 mins by liquid chromatography/tandem mass spectroscopy2012Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 40, Issue:7
In vitro hepatotoxicity and cytochrome P450 induction and inhibition characteristics of carnosic acid, a dietary supplement with antiadipogenic properties.
AID1850549Thermal stabilization of wildtype beta catenin ARD (148 to 662 residues) (unknown origin) assessed as change in melting temperature at 125 uM by DSF method2022Journal of medicinal chemistry, 05-26, Volume: 65, Issue:10
Biophysical Survey of Small-Molecule β-Catenin Inhibitors: A Cautionary Tale.
AID1756081Antibiofilm activity against Acinetobacter baumannii ATCC 19606 assessed as inhibition of bacterial metabolism within the biofilm at 8 ug/ml measured after 48 hrs by MTT assay relative to control
AID1246298Antiproliferative activity against human triple-negative MDA-MB-231 cells at <= 50 uM after 72 hrs by CellTiter-Glo assay2015European journal of medicinal chemistry, Sep-18, Volume: 102(+)-Dehydroabietylamine derivatives target triple-negative breast cancer.
AID1209433Time dependent inhibition of CYP2B6 activity in human hepatocytes after 30 mins by liquid chromatography/tandem mass spectroscopy2012Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 40, Issue:7
In vitro hepatotoxicity and cytochrome P450 induction and inhibition characteristics of carnosic acid, a dietary supplement with antiadipogenic properties.
AID1209434Time dependent inhibition of CYP2C8 activity in human hepatocytes after 30 mins by liquid chromatography/tandem mass spectroscopy2012Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 40, Issue:7
In vitro hepatotoxicity and cytochrome P450 induction and inhibition characteristics of carnosic acid, a dietary supplement with antiadipogenic properties.
AID471764Inhibition of HIV1 protease2009Journal of natural products, Nov, Volume: 72, Issue:11
Inhibition of the dimerization and active site of HIV-1 protease by secondary metabolites from the Vietnamese mushroom Ganoderma colossum.
AID335901Antioxidant activity assessed as DPPH free radical scavenging activity after 30 mins2002Journal of natural products, Sep, Volume: 65, Issue:9
Oxidation, reduction, and methylation of carnosic acid by Nocardia.
AID1756076Antibiofilm activity against Acinetobacter baumannii ATCC 19606 assessed as inhibition of bacterial metabolism within the biofilm at 4 ug/ml measured after 48 hrs by MTT assay relative to control
AID1209432Time dependent inhibition of CYP1A2 activity in human hepatocytes after 30 mins by liquid chromatography/tandem mass spectroscopy2012Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 40, Issue:7
In vitro hepatotoxicity and cytochrome P450 induction and inhibition characteristics of carnosic acid, a dietary supplement with antiadipogenic properties.
AID335103Antiviral activity against HIV1 replication infected in human MT2 cells assessed as reduction in plaque formation after 3 days by MTT assay1993Journal of natural products, Aug, Volume: 56, Issue:8
Inhibitory effect of carnosic acid on HIV-1 protease in cell-free assays [corrected].
AID1756080Antibiofilm activity against Staphylococcus aureus ATCC 25923 assessed as inhibition of bacterial metabolism within the biofilm at 8 ug/ml measured after 48 hrs by MTT assay relative to control
AID1209431Induction of SULT2A1 mRNA expression in human hepatocytes at 10 uM after 48 hrs relative to untreated control2012Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 40, Issue:7
In vitro hepatotoxicity and cytochrome P450 induction and inhibition characteristics of carnosic acid, a dietary supplement with antiadipogenic properties.
AID1756067Antibiofilm activity against Pseudomonas aeruginosa ATCC 50071 assessed as inhibition of biofilm formation at 8 ug/ml measured after 48 hrs by crystal violet staining based assay relative to control
AID1246299Cytotoxicity against HEK293 cells at <= 50 uM after 72 hrs by CellTiter-Glo assay2015European journal of medicinal chemistry, Sep-18, Volume: 102(+)-Dehydroabietylamine derivatives target triple-negative breast cancer.
AID1617575Cytotoxicity against human MIAPaCa2 cells assessed as decrease in cell growth measured after 72 hrs by MTT assay2019Journal of medicinal chemistry, 12-12, Volume: 62, Issue:23
Farnesyl Pyrophosphate Synthase as a Target for Drug Development: Discovery of Natural-Product-Derived Inhibitors and Their Activity in Pancreatic Cancer Cells.
AID744353Cytotoxicity against E15 stage mouse primary cortical neurons at 50 uM by MTS assay2013Bioorganic & medicinal chemistry, May-01, Volume: 21, Issue:9
Structure activity relationship of phenolic diterpenes from Salvia officinalis as activators of the nuclear factor E2-related factor 2 pathway.
AID1756068Antibiofilm activity against Staphylococcus aureus ATCC 25923 assessed as inhibition of biofilm formation at 8 ug/ml measured after 48 hrs by crystal violet staining based assay relative to control
AID1209428Induction of apoptosis in human hepatocytes assessed as caspase 3/7 activation by caspase-Glo 3/7 assay2012Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 40, Issue:7
In vitro hepatotoxicity and cytochrome P450 induction and inhibition characteristics of carnosic acid, a dietary supplement with antiadipogenic properties.
AID1209437Time dependent inhibition of CYP2D6 activity in human hepatocytes after 30 mins by liquid chromatography/tandem mass spectroscopy2012Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 40, Issue:7
In vitro hepatotoxicity and cytochrome P450 induction and inhibition characteristics of carnosic acid, a dietary supplement with antiadipogenic properties.
AID1756063Antibiofilm activity against Staphylococcus aureus ATCC 25923 assessed as inhibition of biofilm formation at 4 ug/ml measured after 48 hrs by crystal violet staining based assay relative to control
AID335105Inhibition of pig pepsin up to 10 ug/ml1993Journal of natural products, Aug, Volume: 56, Issue:8
Inhibitory effect of carnosic acid on HIV-1 protease in cell-free assays [corrected].
AID1209442Cytotoxicity against human hepatocytes assessed as cytoplasm granulation with vacuoles after 24 hrs at 50 to 100 uM2012Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 40, Issue:7
In vitro hepatotoxicity and cytochrome P450 induction and inhibition characteristics of carnosic acid, a dietary supplement with antiadipogenic properties.
AID1756084Antibiofilm activity against Escherichia coli DSM 8579 assessed as inhibition of bacterial metabolism within the biofilm at 80 ug/ml measured after 48 hrs by MTT assay relative to control
AID1756071Antibiofilm activity against Escherichia coli DSM 8579 assessed as inhibition of biofilm formation at 40 ug/ml measured after 48 hrs by crystal violet staining based assay relative to control
AID1209426Cytotoxicity against human hepatocytes assessed as reduction in cell viability after 24 hrs by LDH release assay2012Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 40, Issue:7
In vitro hepatotoxicity and cytochrome P450 induction and inhibition characteristics of carnosic acid, a dietary supplement with antiadipogenic properties.
AID1756083Antibiofilm activity against Escherichia coli DSM 8579 assessed as inhibition of bacterial metabolism within the biofilm at 40 ug/ml measured after 48 hrs by MTT assay relative to control
AID1756069Antibiofilm activity against Acinetobacter baumannii ATCC 19606 assessed as inhibition of biofilm formation at 8 ug/ml measured after 48 hrs by crystal violet staining based assay relative to control
AID1850536Binding affinity to N-terminal FLAG tagged beta catenin alpha helix (H1 - 141 to 149 aa) of armadillo repeat domain (unknown origin) by STD/HSQC based NMR analysis2022Journal of medicinal chemistry, 05-26, Volume: 65, Issue:10
Biophysical Survey of Small-Molecule β-Catenin Inhibitors: A Cautionary Tale.
AID744356Activation of Nrf2/ARE in E15 stage mouse primary cortical neurons at 6.25 to 50 uM after 48 hrs by human placental alkaline phosphatase reporter gene assay2013Bioorganic & medicinal chemistry, May-01, Volume: 21, Issue:9
Structure activity relationship of phenolic diterpenes from Salvia officinalis as activators of the nuclear factor E2-related factor 2 pathway.
AID1756074Antibiofilm activity against Pseudomonas aeruginosa ATCC 50071 assessed as inhibition of bacterial metabolism within the biofilm at 4 ug/ml measured after 48 hrs by MTT assay relative to control
AID335101Inhibition of HIV1 recombinant protease expressed in Escherichia coli BL21 (DE3) cells by SDS-PAGE1993Journal of natural products, Aug, Volume: 56, Issue:8
Inhibitory effect of carnosic acid on HIV-1 protease in cell-free assays [corrected].
AID1336784Inhibition of pancreatic lipase (unknown origin) assessed as decrease in release of fatty acid from triolein incubated for 30 mins by phenolphthalein-baed titrimetric method2017Bioorganic & medicinal chemistry, 02-01, Volume: 25, Issue:3
Synthesis, functionalization and biological activity of arylated derivatives of (+)-estrone.
AID1308849Competitive inhibition of wild type beta-catenin (unknown origin) expressed in Escherichia coli BL21 DE3 interaction with N-terminally biotinylated human BCL9 (350 to 375 residues) by alpha screen assay2016ACS medicinal chemistry letters, May-12, Volume: 7, Issue:5
Structure-Based Design of 1,4-Dibenzoylpiperazines as β-Catenin/B-Cell Lymphoma 9 Protein-Protein Interaction Inhibitors.
AID1617574Cytotoxicity against human PANC1 cells assessed as decrease in cell growth measured after 72 hrs by MTT assay2019Journal of medicinal chemistry, 12-12, Volume: 62, Issue:23
Farnesyl Pyrophosphate Synthase as a Target for Drug Development: Discovery of Natural-Product-Derived Inhibitors and Their Activity in Pancreatic Cancer Cells.
AID1209436Time dependent inhibition of CYP2C19 activity in human hepatocytes after 30 mins by liquid chromatography/tandem mass spectroscopy2012Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 40, Issue:7
In vitro hepatotoxicity and cytochrome P450 induction and inhibition characteristics of carnosic acid, a dietary supplement with antiadipogenic properties.
AID1756066Antibiofilm activity against Listeria monocytogenes ATCC 7644 assessed as inhibition of biofilm formation at 8 ug/ml measured after 48 hrs by crystal violet staining based assay relative to control
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (373)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (0.27)18.7374
1990's9 (2.41)18.2507
2000's59 (15.82)29.6817
2010's237 (63.54)24.3611
2020's67 (17.96)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 55.23

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index55.23 (24.57)
Research Supply Index5.99 (2.92)
Research Growth Index5.97 (4.65)
Search Engine Demand Index91.65 (26.88)
Search Engine Supply Index2.06 (0.95)

This Compound (55.23)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (0.25%)5.53%
Reviews18 (4.55%)6.00%
Case Studies0 (0.00%)4.05%
Observational1 (0.25%)0.25%
Other376 (94.95%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Histologic Comparison of Healing After Tooth Extraction With Ridge Preservation Using Two Different Xenografts [NCT03769376]38 participants (Actual)Interventional2019-05-22Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

TrialOutcome
NCT03769376 (2) [back to overview]New Bone Formation at Extraction/Xenograft Site Measured Clinically With Dental Probe at 16-20 Weeks
NCT03769376 (2) [back to overview]New Bone Formation at Extraction/Xenograft Site Measured by Histological Evaluation at 16-20 Weeks

New Bone Formation at Extraction/Xenograft Site Measured Clinically With Dental Probe at 16-20 Weeks

The boney ridge height on both the buccal/lingual and width in area of the extraction/xenograft site as measured at time of implant placement with an intra-oral dental probe at 16-20 weeks after extraction. Percent change in ridge width from baseline is reported (NCT03769376)
Timeframe: Baseline to 16-20 weeks

InterventionPercent (Mean)
Bio-Oss®15.38
Salvin-Oss®9.09

[back to top]

New Bone Formation at Extraction/Xenograft Site Measured by Histological Evaluation at 16-20 Weeks

The amount of new bone formation at the tooth extraction/xenograft site as measured by the percent of vital bone, residual graft, and connective tissue observed in a histological sample (a bone biopsy) obtained at the time of dental implant insertion, 16-20 weeks after extraction. (NCT03769376)
Timeframe: Baseline to 16-20 weeks

,
InterventionPercent (Mean)
Vital boneResidual graftConnective Tissue/other
Bio-Oss®29.3814.0256.61
Salvin-Oss®32.0516.5651.39

[back to top]